{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:12:44Z","timestamp":1784304764953,"version":"3.55.0"},"reference-count":10,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is the second most common neurodegenerative disorder affecting more than 10 million people worldwide [...]<\/jats:p>","DOI":"10.3390\/ijms26199564","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T15:38:55Z","timestamp":1759246735000},"page":"9564","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Special Issue: \u201cNew Challenges of Parkinson\u2019s Disease\u201d"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2022-3386","authenticated-orcid":false,"given":"Cristina","family":"Agliardi","sequence":"first","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, via Capecelatro 66, 20148 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9461-5927","authenticated-orcid":false,"given":"Franca Rosa","family":"Guerini","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi ONLUS, via Capecelatro 66, 20148 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14737167.2024.2390042","article-title":"Burden of non-motor symptoms of Parkinson\u2019s disease: Cost-of-illness and quality-of-life estimates through a scoping review","volume":"25","author":"Jorgensen","year":"2025","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: Clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/01.WNL.0000068010.82167.CF","article-title":"Longitudinal outcome of Parkinson\u2019s disease patients with psychosis","volume":"60","author":"Factor","year":"2003","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1532-5415.1991.tb03627.x","article-title":"Behavioral complications of drug treatment of Parkinson\u2019s disease","volume":"39","author":"Cummings","year":"1991","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","article-title":"The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1007\/s10072-022-06316-0","article-title":"Research progress in the early diagnosis of Parkinson\u2019s disease","volume":"43","author":"Xie","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_7","first-page":"121","article-title":"Diagnostic challenges in Parkinson\u2019s disease","volume":"55","author":"Alster","year":"2021","journal-title":"Neurol. I Neurochir. Pol."},{"key":"ref_8","first-page":"304","article-title":"Biomarkers in Parkinson\u2019s disease: Advances and strategies","volume":"97","author":"Delenclos","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e13284","DOI":"10.1111\/bpa.13284","article-title":"Comparing GBA1-Parkinson\u2019s disease and idiopathic Parkinson\u2019s disease: \u03b1-Synuclein oligomers and synaptic density as biomarkers in the skin biopsy","volume":"34","author":"Mazzetti","year":"2024","journal-title":"Brain Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/mdc3.13753","article-title":"Status of current biofluid biomarkers in Parkinson\u2019s disease","volume":"10","author":"Mollenhauer","year":"2023","journal-title":"Mov. Disord. Clin. Pract."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9564\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:10:49Z","timestamp":1759896649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":10,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ijms26199564"],"URL":"https:\/\/doi.org\/10.3390\/ijms26199564","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}